TH4984010R19
TH4984010R19
MEGA_MEGA LIFESCIENCES
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 29.43B EUR | 29.46B EUR | 29.46B EUR | 25.01B EUR |
Enterprise Value | 26.11B EUR | 26.51B EUR | 25.85B EUR | 21.42B EUR |
Valuation Multiples | ||||
Trailing P/E | 13.5x | 13.45x | 14.26x | 17.11x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 2.03x | 2.03x | 2.05x | 2.29x |
Price to Book | 2.84x | 2.85x | 2.8x | 2.45x |
EV/Revenue | 1.8x | 1.83x | 1.8x | 1.96x |
EV/EBITDA | 8.07x | 7.93x | 7.72x | 8.41x |
Price to FCF (P/FCF) | 17.08x | 13.34x | 11.49x | 12.66x |
EV/FCF | 15.16x | 12x | 10.08x | 10.84x |
FCF Yield | 5.85% | 7.5% | 8.71% | 7.9% |